首页|经胃管微创注入肺表面活性物质联合经鼻持续气道正压通气对新生儿呼吸窘迫综合征患儿血氧状态及炎症反应的影响

经胃管微创注入肺表面活性物质联合经鼻持续气道正压通气对新生儿呼吸窘迫综合征患儿血氧状态及炎症反应的影响

扫码查看
目的 分析经胃管微创注入肺表面活性物质(PS)联合经鼻持续气道正压通气(NCPAP)对新生儿呼吸窘迫综合征(NRDS)患儿血氧状态及炎症反应的影响。方法 择取2017年2月至2022年3月收治的60例NRDS患儿为研究对象,根据入院时间将其分为对照组(2017年2月至2019年8月)和观察组(2019年9月至2022年3月),各30例。对照组给予布地奈德联合NCPAP治疗,观察组在对照组基础上加用经胃管微创注入PS治疗。比较两组的治疗效果。结果 治疗前,两组的动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)、吸入氧浓度(FiO2)比较,差异无统计学意义(P>0。05);治疗后,观察组的PaO2高于对照组,PaCO2及FiO2低于对照组,差异具有统计学意义(P<0。05)。治疗前,两组的C反应蛋白(CRP)、白细胞介素-18(IL-18)水平及白细胞计数(WBC)比较,差异无统计学意义(P>0。05);治疗后,观察组的CRP、IL-18水平及WBC均低于对照组,差异具有统计学意义(P<0。05)。观察组的并发症总发生率低于对照组,差异具有统计学意义(P<0。05)。治疗前,两组的呼吸系统阻力(Rrs)、肺动态顺应性(Crs)比较,差异无统计学意义(P>0。05);治疗后,观察组的Rrs低于对照组,Crs高于对照组,差异具有统计学意义(P<0。05)。结论 经胃管微创注入PS联合NCPAP可减轻NRDS患儿的炎症反应,降低并发症发生率,促进肺功能及血氧状态恢复,值得推广。
Effects of minimally invasive injection of pulmonary surfactant through gastric tube combined with nasal continuous positive airway pressure on blood oxygen status and inflammatory response in children with neonatal respiratory distress syndrome
Objective To analyze the effects of minimally invasive injection of pulmonary surfactant(PS)through gastric tube combined with nasal continuous positive airway pressure(NCPAP)on blood oxygen status and inflammatory response in children with neonatal respiratory distress syndrome(NRDS).Methods Sixty children with NRDS admitted from February 2017 to March 2022 were selected as the study subjects.According to the time of admission,the children were divided into control group(February 2017 to August 2019)and observation group(September 2019 to March 2022),with 30 cases in each group.The control group was treated with budesonide combined with NCPAP,and the observation group was treated with minimally invasive injection of PS through gastric tube on the basis of the control group.The therapeutic effects of the two groups were compared.Results Before treatment,there were no significant differences in partial pressure of oxygen in arterial blood(PaO2),partial pressure of carbon dioxide(PaCO2)and fraction of inspiration oxygen(FiO2)between the two groups(P>0.05);after treatment,the PaO2 in the observation group was higher than that in the control group,and the PaCO2 and FiO2 were lower than those in the control group,and the differences were statistically significant(P<0.05).Before treatment,there were no significant differences in the levels of C-reactive protein(CRP),interleukin-18(IL-18)and white blood cell count(WBC)between the two groups(P>0.05);after treatment,the levels of CRP,IL-18 and WBC in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The total incidence of complications in the observation group was lower than that in the control group,and the difference was statistically significant(P<0.05).Before treatment,there were no significant differences in respiratory resistance(Rrs)and compliance of the respiratory system(Crs)between the two groups(P>0.05);after treatment,the Rrs of the observation group was lower than that of the control group,and the Crs was higher than that of the control group,and the differences were statistically significant(P<0.05).Conclusion Minimally invasive injection of PS through gastric tube combined with NCPAP can reduce the inflammatory response,diminish the incidence of complications,and promote the recovery of lung function and blood oxygen status in children with NRDS,which is worthy of promotion.

minimally invasive gastric tube injectionpulmonary surfactantnasal continuous positive airway pressureneonatal respiratory distress syndromeblood oxygen statusinflammatory response

郭小霞、谢秀春、吴夏颖、王苗、李静

展开 >

陕西中医药大学附属医院儿科,陕西咸阳,712000

西电集团医院新生儿科,陕西西安,710077

胃管微创注入 肺表面活性物质 经鼻持续气道正压通气 新生儿呼吸窘迫综合征 血氧状态 炎症反应

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(19)